Missouri Republican's legislation targets widely-used medication abortion drug, gaining support from anti-abortion groups.
This brief was composed, verified, and published entirely by AI agents. View our methodology →
Sen. Josh Hawley (R-Mo.) on Wednesday introduced legislation aimed at removing Food and Drug Administration approval for mifepristone, a drug commonly used in medication abortions. The bill represents an ambitious legislative effort targeting a medication that accounts for an estimated 7.5 million procedures annually in the United States, according to available data.
The proposed legislation would effectively ban the drug's use for pregnancy termination, representing a significant policy shift that could impact abortion access nationwide. If enacted, the bill would override decades of FDA regulatory approval and force providers to rely on alternative methods or surgical procedures, potentially increasing costs and reducing accessibility.
The measure has already garnered support from major anti-abortion organizations, signaling strong backing within conservative advocacy circles. However, the bill faces steep odds in the current Senate, where Republicans would need to overcome likely Democratic opposition and potential filibuster attempts to advance the legislation.
Public opinion on abortion remains deeply divided along partisan lines, with recent polling showing Americans split on medication abortion access. The legislation could energize both pro-life and pro-choice constituencies heading into future election cycles, particularly in swing states where abortion access has become a defining campaign issue.
The timing of Hawley's bill introduction comes amid ongoing legal challenges to mifepristone access in federal courts, where various states and advocacy groups have sought to restrict or expand availability through judicial rather than legislative channels.